Literature DB >> 6206410

Conversion of myelin-associated glycoprotein (MAG) to a smaller derivative by calcium activated neutral protease (CANP)-like enzyme in myelin and inhibition by E-64 analogue.

S Sato, K Yanagisawa, T Miyatake.   

Abstract

Using the immunoblot technique, we found that an incubation of purified human myelin in 10 mM Tris-HCl buffer at pH 7.5 resulted in the conversion of the myelin-associated glycoprotein (MAG) to a smaller derivative (dMAG). Exogenously added 5 mM CaCl2 accelerated the conversion of MAG. In buffer containing more than 100 microM of EGTA, the conversion was inhibited. In addition, the existence of endogenous calcium in purified myelin was confirmed using atomic absorption spectroscopy. The conversion was also inhibited partially by one of the thiol protease inhibitors, E-64 analogue (E-64-a). These observations suggest that the conversion of MAG is mediated by calcium-activated neutral protease (CANP)-like enzyme.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6206410     DOI: 10.1007/BF00964509

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  16 in total

1.  A rapid procedure for selectively isolating the major glycoprotein from purified rat brain myelin.

Authors:  R H Quarles; C F Pasnak
Journal:  Biochem J       Date:  1977-06-01       Impact factor: 3.857

2.  Myelination in rat brain: method of myelin isolation.

Authors:  W T Norton; S E Poduslo
Journal:  J Neurochem       Date:  1973-10       Impact factor: 5.372

3.  Evidence for the close association of a glycoprotein with myelin in rat brain.

Authors:  R H Quarles; J L Everly; R O Brady
Journal:  J Neurochem       Date:  1973-11       Impact factor: 5.372

Review 4.  Glycoproteins from central and peripheral myelin.

Authors:  R H Quarles
Journal:  Prog Clin Biol Res       Date:  1980

5.  Susceptibility of the myelin-associated glycoprotein and basic protein to a neutral protease in highly purified myelin from human and rat brain.

Authors:  S Sato; R H Quarles; R O Brady
Journal:  J Neurochem       Date:  1982-07       Impact factor: 5.372

6.  Maturation of the head of bacteriophage T4. I. DNA packaging events.

Authors:  U K Laemmli; M Favre
Journal:  J Mol Biol       Date:  1973-11-15       Impact factor: 5.469

7.  Myelin-associated glycoprotein demonstrated immunocytochemically in myelin and myelin-forming cells of developing rat.

Authors:  N H Sternberger; R H Quarles; Y Itoyama; H D Webster
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

8.  Immunocytochemical observations on the distribution of myelin-associated glycoprotein and myelin basic protein in multiple sclerosis lesions.

Authors:  Y Itoyama; N H Sternberger; H D Webster; R H Quarles; S R Cohen; E P Richardson
Journal:  Ann Neurol       Date:  1980-02       Impact factor: 10.422

9.  Myelin-associated glycoprotein is the antigen for a monoclonal IgM in polyneuropathy.

Authors:  P E Braun; D E Frail; N Latov
Journal:  J Neurochem       Date:  1982-11       Impact factor: 5.372

10.  Elevated neutral protease activity in myelin from brains of patients with multiple sclerosis.

Authors:  S Sato; R H Quarles; R O Brady; W W Tourtellotte
Journal:  Ann Neurol       Date:  1984-03       Impact factor: 10.422

View more
  15 in total

1.  Degradation products of myelin-oligodendrocyte-associated proteins in a light CNS subcellular fraction.

Authors:  H Persson
Journal:  Neurochem Res       Date:  1991-10       Impact factor: 3.996

2.  The regional and subcellular distribution of calcium activated neutral proteinase (CANP) in the bovine central nervous system.

Authors:  A K Chakrabarti; N L Banik; J M Powers; E L Hogan
Journal:  Neurochem Res       Date:  1989-03       Impact factor: 3.996

3.  Enzymatic and nonenzymatic degradation of myelin basic protein.

Authors:  G E Deibler; L F Boyd; M W Kies
Journal:  Neurochem Res       Date:  1984-10       Impact factor: 3.996

4.  Degradation of myelin basic protein by calcium-activated neutral protease (CANP) in human brain and inhibition by E-64 analogue.

Authors:  K Yanagisawa; S Sato; N Amaya; T Miyatake
Journal:  Neurochem Res       Date:  1983-10       Impact factor: 3.996

5.  Cleavage of the P0 glycoprotein of the rat peripheral nerve myelin: tentative identification of cleavage site and evidence for the precursor-product relationship.

Authors:  H C Agrawal; D Agrawal; A W Strauss
Journal:  Neurochem Res       Date:  1990-10       Impact factor: 3.996

6.  Expression of oligodendroglia and Schwann cell markers in human nervous system tumors. An immunomorphological study and western blot analysis.

Authors:  K Schwechheimer; P Gass; H H Berlet
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

7.  Characterization of myelin-associated glycoprotein (MAG) proteolysis in the human central nervous system.

Authors:  J W Stebbins; H Jaffe; J R Möller
Journal:  Neurochem Res       Date:  1998-07       Impact factor: 3.996

8.  Purification of calcium-activated neutral proteinase (CANP) from purified myelin of bovine brain white matter.

Authors:  A K Chakrabarti; N L Banik
Journal:  Neurochem Res       Date:  1988-02       Impact factor: 3.996

9.  Degradation of myelin basic protein in myelin by protease in cerebrospinal fluid and effects of protease inhibitors.

Authors:  T Inuzuka; S Sato; H Baba; T Miyatake
Journal:  Neurochem Res       Date:  1986-10       Impact factor: 3.996

10.  Degradation products of myelin proteins in a light CNS subcellular fraction.

Authors:  H Persson; O Corneliuson
Journal:  Neurochem Res       Date:  1989-12       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.